About Fangliang Zhang, Ph.D.
Form D filings for Legend Biotech from 2020 to 2023 list Fangliang Zhang, Ph.D. as director.
Fangliang Zhang, Ph.D. first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Fangliang Zhang, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Fangliang Zhang, Ph.D. works with at each company, as listed on that company's latest Form D.
Legend Biotech Corp · Form D, Apr 28, 2023
LM
Li Mao, MD
Director
TH
Tomas Heyman
Director
DD
Darren Ji, M.D., Ph.D.
Director
LD
Li Zhu, Ph.D.
Director
LM
Lori Macomber
Chief Financial Officer
PD
Patrick Casey, Ph.D.
Director
YS
Ye Wang, M.S.
Director
PC
Philip Yau, CPA
Director
YD
Ying Huang, Ph.D.
Executive officer and director
CD
Corazon Sanders, Ph.D.
Director